Jinwu Financial News | Medical Thinking Health (02138) surged in the afternoon. As of press release, it rose 4.23% to HK$0.74, with a turnover of HK$0.37 million.
According to the news, the company announced results for the six months ended September 30, 2024. Profit attributable to the equity shareholders of the company was HK$14.097 million, up 111.95% year on year, with a basic profit of HK1.2 cents per share. An interim dividend of HK$1 per share is payable. During the period, the Group's total revenue was HK$2.063 billion, down 2.8% year on year, including medical business revenue of HK$1.264 billion, a decrease of 3.7% year on year, aesthetic medicine and beauty and wellness business revenue of HK$0.63 billion, a decrease of 5.4% year on year, and revenue from veterinary and other businesses of HK$0.169 billion, up 18.3% year on year.